Our Reports
Automotive ReportsElectronics & SemiconductorTelecom & ITTechnology & ITConsumer GoodsHealthcareFood & BeveragesChemical
Our Links
About UsContact UsPress ReleaseNewsOur Blogs

Int'l : +1(646) 600-5072 | query@kbvresearch.com

Global HIV Injection Market Size, Share & Trends Analysis Report By Distribution Channel (Hospital Pharmacy, Drugs Stores & Retail Pharmacies, and Others), By Regional Outlook and Forecast, 2023 - 2030

Published Date : 29-Mar-2024

Pages: 143

Formats: PDF

The Global HIV Injection Market size is expected to reach $2.8 billion by 2030, rising at a market growth of 17.6% CAGR during the forecast period.

North America, particularly the United States, has a relatively high prevalence of HIV compared to other regions. Therefore, the North America segment captured $368.07 million revenue in the market in 2022. This high prevalence creates a substantial demand for HIV medications, including injectable therapies. North America is at the forefront of HIV research and treatment, leading to the development of new and innovative HIV medications, including injectable therapies.

HIV Injection Market Size - Global Opportunities and Trends Analysis Report 2019-2030

The escalating prevalence of HIV/AIDS necessitates the development of more efficacious treatment modalities to alleviate symptoms and sustain life. This increased demand has driven pharmaceutical companies and researchers to develop new and innovative HIV injections to meet the growing needs of patients. Thus, the increasing prevalence of HIV is supporting the growth of the market.

Additionally, the innovative formulations offer several advantages over traditional oral medications, driving their adoption and increasing demand in the market. Injectable therapies typically require less frequent dosing than oral medications, which can be particularly beneficial for patients with difficulty adhering to complex medication schedules. Therefore, the development of innovative injectable formulations for the treatment of HIV/AIDS has had a positive impact on the demand for HIV injections.

However, the high cost of HIV treatment, including injectable medications, remains a significant barrier to access for many people living with HIV/AIDS, particularly in low- and middle-income countries. The cost of HIV treatment can include not only the price of the medication itself but also the cost of regular monitoring, laboratory tests, and healthcare provider visits, which can quickly add up to a substantial financial burden for patients. Hence, the high cost might hamper the expansion of the market.

The COVID-19 pandemic had a significant impact on the market, affecting various aspects of the supply chain and patient access to treatment. Raw material shortages and manufacturing delays followed disruptions in the global supply chain, which affected HIV medications, including injectable therapies. These disruptions impacted their availability in some regions, potentially leading to treatment interruptions for patients. Thus, the pandemic affected the market negatively

By Distribution Channel Analysis

Based on distribution channel, the market is divided into hospital pharmacy, drug stores & retail pharmacies, and others. The hospital pharmacy segment procured 46.2% revenue share in the market in 2022. Hospitals, clinics, and other healthcare facilities are major distribution points for HIV injections. They receive medications from pharmaceutical companies or wholesalers and distribute them to patients as part of their treatment regimens.

HIV Injection Market Share and Industry Analysis Report 2022

By Regional Analysis

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The LAMEA segment witnessed 5.3% revenue share in the market in 2022. The LAMEA region has a relatively high prevalence of HIV, with certain countries in sub-Saharan Africa experiencing particularly high rates of infection. Governments in the LAMEA region have implemented various initiatives to address the HIV/AIDS epidemic, including funding for HIV/AIDS programs and improving access to treatment.

Free Valuable Insights: Global HIV Injection Market size to reach USD 2.8 Billion by 2030

HIV Injection Market Report Coverage
Report Attribute Details
Market size value in 2022 USD 787.02 Million
Market size forecast in 2030 USD 2.8 Billion
Base Year 2022
Historical Period 2019 to 2021
Forecast Period 2023 to 2030
Revenue Growth Rate CAGR of 17.6% from 2023 to 2030
Number of Pages 143
Number of Tables 170
Report coverage Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Porter’s 5 Forces Analysis, Company Profiling, Companies Strategic Developments, SWOT Analysis, Winning Imperatives
Segments covered Distribution Channel, Region
Country scope
  • North America (US, Canada, Mexico, and Rest of North America)
  • Europe (Germany, UK, France, Russia, Spain, Italy, and Rest of Europe)
  • Asia Pacific (China, India, Japan, South Korea, Singapore, Malaysia, and Rest of Asia Pacific)
  • LAMEA (Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA)
Companies Included GlaxoSmithKline PLC (GSK), Gilead Sciences, Inc., ImmunityBio, Inc., F. Hoffmann-La Roche Ltd., Theratechnologies Inc., Viriom, Inc., AbbVie, Inc., Brii Biosciences Limited, Shionogi & Co., Ltd., Boehringer Ingelheim International GmbH

List of Key Companies Profiled

  • GlaxoSmithKline PLC (GSK)
  • Gilead Sciences, Inc.
  • ImmunityBio, Inc.
  • F.Hoffmann-La Roche Ltd.
  • Theratechnologies Inc.
  • Viriom, Inc.
  • AbbVie, Inc.
  • Brii Biosciences Limited
  • Shionogi & Co., Ltd.
  • Boehringer Ingelheim International GmbH

HIV Injection Market Report Segmentation

By Distribution Channel

  • Hospital Pharmacy
  • Drugs Stores & Retail Pharmacies
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global HIV Injection Market, by Distribution Channel
1.4.2 Global HIV Injection Market, by Geography
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Opportunities
3.2.3 Market Restraints
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis

Chapter 4. Global HIV Injection Market by Distribution Channel
4.1 Global Hospital Pharmacy Market by Region
4.2 Global Drugs Stores & Retail Pharmacies Market by Region
4.3 Global Others Market by Region

Chapter 5. Global HIV Injection Market by Region
5.1 North America HIV Injection Market
5.1.1 North America HIV Injection Market by Distribution Channel
5.1.1.1 North America Hospital Pharmacy Market by Country
5.1.1.2 North America Drugs Stores & Retail Pharmacies Market by Country
5.1.1.3 North America Others Market by Country
5.1.2 North America HIV Injection Market by Country
5.1.2.1 US HIV Injection Market
5.1.2.1.1 US HIV Injection Market by Distribution Channel
5.1.2.2 Canada HIV Injection Market
5.1.2.2.1 Canada HIV Injection Market by Distribution Channel
5.1.2.3 Mexico HIV Injection Market
5.1.2.3.1 Mexico HIV Injection Market by Distribution Channel
5.1.2.4 Rest of North America HIV Injection Market
5.1.2.4.1 Rest of North America HIV Injection Market by Distribution Channel
5.2 Europe HIV Injection Market
5.2.1 Europe HIV Injection Market by Distribution Channel
5.2.1.1 Europe Hospital Pharmacy Market by Country
5.2.1.2 Europe Drugs Stores & Retail Pharmacies Market by Country
5.2.1.3 Europe Others Market by Country
5.2.2 Europe HIV Injection Market by Country
5.2.2.1 Germany HIV Injection Market
5.2.2.1.1 Germany HIV Injection Market by Distribution Channel
5.2.2.2 UK HIV Injection Market
5.2.2.2.1 UK HIV Injection Market by Distribution Channel
5.2.2.3 France HIV Injection Market
5.2.2.3.1 France HIV Injection Market by Distribution Channel
5.2.2.4 Russia HIV Injection Market
5.2.2.4.1 Russia HIV Injection Market by Distribution Channel
5.2.2.5 Spain HIV Injection Market
5.2.2.5.1 Spain HIV Injection Market by Distribution Channel
5.2.2.6 Italy HIV Injection Market
5.2.2.6.1 Italy HIV Injection Market by Distribution Channel
5.2.2.7 Rest of Europe HIV Injection Market
5.2.2.7.1 Rest of Europe HIV Injection Market by Distribution Channel
5.3 Asia Pacific HIV Injection Market
5.3.1 Asia Pacific HIV Injection Market by Distribution Channel
5.3.1.1 Asia Pacific Hospital Pharmacy Market by Country
5.3.1.2 Asia Pacific Drugs Stores & Retail Pharmacies Market by Country
5.3.1.3 Asia Pacific Others Market by Country
5.3.2 Asia Pacific HIV Injection Market by Country
5.3.2.1 China HIV Injection Market
5.3.2.1.1 China HIV Injection Market by Distribution Channel
5.3.2.2 Japan HIV Injection Market
5.3.2.2.1 Japan HIV Injection Market by Distribution Channel
5.3.2.3 India HIV Injection Market
5.3.2.3.1 India HIV Injection Market by Distribution Channel
5.3.2.4 South Korea HIV Injection Market
5.3.2.4.1 South Korea HIV Injection Market by Distribution Channel
5.3.2.5 Singapore HIV Injection Market
5.3.2.5.1 Singapore HIV Injection Market by Distribution Channel
5.3.2.6 Malaysia HIV Injection Market
5.3.2.6.1 Malaysia HIV Injection Market by Distribution Channel
5.3.2.7 Rest of Asia Pacific HIV Injection Market
5.3.2.7.1 Rest of Asia Pacific HIV Injection Market by Distribution Channel
5.4 LAMEA HIV Injection Market
5.4.1 LAMEA HIV Injection Market by Distribution Channel
5.4.1.1 LAMEA Hospital Pharmacy Market by Country
5.4.1.2 LAMEA Drugs Stores & Retail Pharmacies Market by Country
5.4.1.3 LAMEA Others Market by Country
5.4.2 LAMEA HIV Injection Market by Country
5.4.2.1 Brazil HIV Injection Market
5.4.2.1.1 Brazil HIV Injection Market by Distribution Channel
5.4.2.2 Argentina HIV Injection Market
5.4.2.2.1 Argentina HIV Injection Market by Distribution Channel
5.4.2.3 UAE HIV Injection Market
5.4.2.3.1 UAE HIV Injection Market by Distribution Channel
5.4.2.4 Saudi Arabia HIV Injection Market
5.4.2.4.1 Saudi Arabia HIV Injection Market by Distribution Channel
5.4.2.5 South Africa HIV Injection Market
5.4.2.5.1 South Africa HIV Injection Market by Distribution Channel
5.4.2.6 Nigeria HIV Injection Market
5.4.2.6.1 Nigeria HIV Injection Market by Distribution Channel
5.4.2.7 Rest of LAMEA HIV Injection Market
5.4.2.7.1 Rest of LAMEA HIV Injection Market by Distribution Channel

Chapter 6. Company Profiles
6.1 GlaxoSmithKline PLC (GSK)
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Regional Analysis
6.1.4 Research & Development Expense
6.1.5 SWOT Analysis
6.1 Gilead Sciences, Inc.
6.1.1 Company overview
6.1.2 Financial Analysis
6.1.3 Research & Development Expenses
6.1.4 SWOT Analysis
6.2 ImmunityBio, Inc.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Regional Analysis
6.2.4 Research & Development Expenses
6.2.5 SWOT Analysis
6.3 F. Hoffmann-La Roche Ltd.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.5 SWOT Analysis
6.4 Theratechnologies Inc.
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Research & Development Expenses
6.4.4 SWOT Analysis
6.5 Viriom, Inc.
6.5.1 Company Overview
6.5.2 SWOT Analysis
6.6 AbbVie, Inc.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Regional Analysis
6.6.4 Research & Development Expense
6.6.5 SWOT Analysis
6.7 Brii Biosciences Limited
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Research & Development Expenses
6.7.4 SWOT Analysis
6.8 Shionogi & Co., Ltd.
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Research & Development Expenses
6.8.4 SWOT Analysis
6.9 Boehringer Ingelheim International GmbH
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Regional & Segmental Analysis
6.9.4 Research & Development Expenses
6.9.5 SWOT Analysis

Chapter 7. Winning Imperatives of HIV Injection Market
TABLE 1 Global HIV Injection Market, 2019 - 2022, USD Million
TABLE 2 Global HIV Injection Market, 2023 - 2030, USD Million
TABLE 3 Global HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 4 Global HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 5 Global Hospital Pharmacy Market by Region, 2019 - 2022, USD Million
TABLE 6 Global Hospital Pharmacy Market by Region, 2023 - 2030, USD Million
TABLE 7 Global Drugs Stores & Retail Pharmacies Market by Region, 2019 - 2022, USD Million
TABLE 8 Global Drugs Stores & Retail Pharmacies Market by Region, 2023 - 2030, USD Million
TABLE 9 Global Others Market by Region, 2019 - 2022, USD Million
TABLE 10 Global Others Market by Region, 2023 - 2030, USD Million
TABLE 11 Global HIV Injection Market by Region, 2019 - 2022, USD Million
TABLE 12 Global HIV Injection Market by Region, 2023 - 2030, USD Million
TABLE 13 North America HIV Injection Market, 2019 - 2022, USD Million
TABLE 14 North America HIV Injection Market, 2023 - 2030, USD Million
TABLE 15 North America HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 16 North America HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 17 North America Hospital Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 18 North America Hospital Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 19 North America Drugs Stores & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 20 North America Drugs Stores & Retail Pharmacies Market by Country, 2023 - 2030, USD Million
TABLE 21 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 22 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 23 North America HIV Injection Market by Country, 2019 - 2022, USD Million
TABLE 24 North America HIV Injection Market by Country, 2023 - 2030, USD Million
TABLE 25 US HIV Injection Market, 2019 - 2022, USD Million
TABLE 26 US HIV Injection Market, 2023 - 2030, USD Million
TABLE 27 US HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 28 US HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 29 Canada HIV Injection Market, 2019 - 2022, USD Million
TABLE 30 Canada HIV Injection Market, 2023 - 2030, USD Million
TABLE 31 Canada HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 32 Canada HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 33 Mexico HIV Injection Market, 2019 - 2022, USD Million
TABLE 34 Mexico HIV Injection Market, 2023 - 2030, USD Million
TABLE 35 Mexico HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 36 Mexico HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 37 Rest of North America HIV Injection Market, 2019 - 2022, USD Million
TABLE 38 Rest of North America HIV Injection Market, 2023 - 2030, USD Million
TABLE 39 Rest of North America HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 40 Rest of North America HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 41 Europe HIV Injection Market, 2019 - 2022, USD Million
TABLE 42 Europe HIV Injection Market, 2023 - 2030, USD Million
TABLE 43 Europe HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 44 Europe HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 45 Europe Hospital Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 46 Europe Hospital Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 47 Europe Drugs Stores & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 48 Europe Drugs Stores & Retail Pharmacies Market by Country, 2023 - 2030, USD Million
TABLE 49 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 50 Europe Others Market by Country, 2023 - 2030, USD Million
TABLE 51 Europe HIV Injection Market by Country, 2019 - 2022, USD Million
TABLE 52 Europe HIV Injection Market by Country, 2023 - 2030, USD Million
TABLE 53 Germany HIV Injection Market, 2019 - 2022, USD Million
TABLE 54 Germany HIV Injection Market, 2023 - 2030, USD Million
TABLE 55 Germany HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 56 Germany HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 57 UK HIV Injection Market, 2019 - 2022, USD Million
TABLE 58 UK HIV Injection Market, 2023 - 2030, USD Million
TABLE 59 UK HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 60 UK HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 61 France HIV Injection Market, 2019 - 2022, USD Million
TABLE 62 France HIV Injection Market, 2023 - 2030, USD Million
TABLE 63 France HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 64 France HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 65 Russia HIV Injection Market, 2019 - 2022, USD Million
TABLE 66 Russia HIV Injection Market, 2023 - 2030, USD Million
TABLE 67 Russia HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 68 Russia HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 69 Spain HIV Injection Market, 2019 - 2022, USD Million
TABLE 70 Spain HIV Injection Market, 2023 - 2030, USD Million
TABLE 71 Spain HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 72 Spain HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 73 Italy HIV Injection Market, 2019 - 2022, USD Million
TABLE 74 Italy HIV Injection Market, 2023 - 2030, USD Million
TABLE 75 Italy HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 76 Italy HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 77 Rest of Europe HIV Injection Market, 2019 - 2022, USD Million
TABLE 78 Rest of Europe HIV Injection Market, 2023 - 2030, USD Million
TABLE 79 Rest of Europe HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 80 Rest of Europe HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 81 Asia Pacific HIV Injection Market, 2019 - 2022, USD Million
TABLE 82 Asia Pacific HIV Injection Market, 2023 - 2030, USD Million
TABLE 83 Asia Pacific HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 84 Asia Pacific HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 85 Asia Pacific Hospital Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 86 Asia Pacific Hospital Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 87 Asia Pacific Drugs Stores & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 88 Asia Pacific Drugs Stores & Retail Pharmacies Market by Country, 2023 - 2030, USD Million
TABLE 89 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
TABLE 90 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
TABLE 91 Asia Pacific HIV Injection Market by Country, 2019 - 2022, USD Million
TABLE 92 Asia Pacific HIV Injection Market by Country, 2023 - 2030, USD Million
TABLE 93 China HIV Injection Market, 2019 - 2022, USD Million
TABLE 94 China HIV Injection Market, 2023 - 2030, USD Million
TABLE 95 China HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 96 China HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 97 Japan HIV Injection Market, 2019 - 2022, USD Million
TABLE 98 Japan HIV Injection Market, 2023 - 2030, USD Million
TABLE 99 Japan HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 100 Japan HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 101 India HIV Injection Market, 2019 - 2022, USD Million
TABLE 102 India HIV Injection Market, 2023 - 2030, USD Million
TABLE 103 India HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 104 India HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 105 South Korea HIV Injection Market, 2019 - 2022, USD Million
TABLE 106 South Korea HIV Injection Market, 2023 - 2030, USD Million
TABLE 107 South Korea HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 108 South Korea HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 109 Singapore HIV Injection Market, 2019 - 2022, USD Million
TABLE 110 Singapore HIV Injection Market, 2023 - 2030, USD Million
TABLE 111 Singapore HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 112 Singapore HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 113 Malaysia HIV Injection Market, 2019 - 2022, USD Million
TABLE 114 Malaysia HIV Injection Market, 2023 - 2030, USD Million
TABLE 115 Malaysia HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 116 Malaysia HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 117 Rest of Asia Pacific HIV Injection Market, 2019 - 2022, USD Million
TABLE 118 Rest of Asia Pacific HIV Injection Market, 2023 - 2030, USD Million
TABLE 119 Rest of Asia Pacific HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 120 Rest of Asia Pacific HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 121 LAMEA HIV Injection Market, 2019 - 2022, USD Million
TABLE 122 LAMEA HIV Injection Market, 2023 - 2030, USD Million
TABLE 123 LAMEA HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 124 LAMEA HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 125 LAMEA Hospital Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 126 LAMEA Hospital Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 127 LAMEA Drugs Stores & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 128 LAMEA Drugs Stores & Retail Pharmacies Market by Country, 2023 - 2030, USD Million
TABLE 129 LAMEA Others Market by Country, 2019 - 2022, USD Million
TABLE 130 LAMEA Others Market by Country, 2023 - 2030, USD Million
TABLE 131 LAMEA HIV Injection Market by Country, 2019 - 2022, USD Million
TABLE 132 LAMEA HIV Injection Market by Country, 2023 - 2030, USD Million
TABLE 133 Brazil HIV Injection Market, 2019 - 2022, USD Million
TABLE 134 Brazil HIV Injection Market, 2023 - 2030, USD Million
TABLE 135 Brazil HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 136 Brazil HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 137 Argentina HIV Injection Market, 2019 - 2022, USD Million
TABLE 138 Argentina HIV Injection Market, 2023 - 2030, USD Million
TABLE 139 Argentina HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 140 Argentina HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 141 UAE HIV Injection Market, 2019 - 2022, USD Million
TABLE 142 UAE HIV Injection Market, 2023 - 2030, USD Million
TABLE 143 UAE HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 144 UAE HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 145 Saudi Arabia HIV Injection Market, 2019 - 2022, USD Million
TABLE 146 Saudi Arabia HIV Injection Market, 2023 - 2030, USD Million
TABLE 147 Saudi Arabia HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 148 Saudi Arabia HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 149 South Africa HIV Injection Market, 2019 - 2022, USD Million
TABLE 150 South Africa HIV Injection Market, 2023 - 2030, USD Million
TABLE 151 South Africa HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 152 South Africa HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 153 Nigeria HIV Injection Market, 2019 - 2022, USD Million
TABLE 154 Nigeria HIV Injection Market, 2023 - 2030, USD Million
TABLE 155 Nigeria HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 156 Nigeria HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 157 Rest of LAMEA HIV Injection Market, 2019 - 2022, USD Million
TABLE 158 Rest of LAMEA HIV Injection Market, 2023 - 2030, USD Million
TABLE 159 Rest of LAMEA HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 160 Rest of LAMEA HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 161 Key Information – GlaxoSmithKline PLC
TABLE 162 Key Information – Gilead Sciences, Inc.
TABLE 163 Key Information – ImmunityBio, Inc.
TABLE 164 Key Information – F. Hoffmann-La Roche Ltd.
TABLE 165 Key Information – Theratechnologies Inc.
TABLE 166 Key Information – Viriom, Inc.
TABLE 167 Key information – AbbVie, Inc.
TABLE 168 Key Information – Brii Biosciences Limited
TABLE 169 Key Information – Shionogi & Co., Ltd.
TABLE 170 Key Information – Boehringer Ingelheim International GmbH

List of Figures
FIG 1 Methodology for the research
FIG 2 Global HIV Injection Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting HIV Injection Market
FIG 4 Porter’s Five Forces Analysis - HIV Injection Market
FIG 5 Global HIV Injection Market share by Distribution Channel, 2022
FIG 6 Global HIV Injection Market share by Distribution Channel, 2030
FIG 7 Global HIV Injection Market by Distribution Channel, 2019 - 2030, USD Million
FIG 8 Global HIV Injection Market share by Region, 2022
FIG 9 Global HIV Injection Market share by Region, 2030
FIG 10 Global HIV Injection Market by Region, 2019 - 2030, USD Million
FIG 11 SWOT Analysis: GlaxoSmithKline PLC
FIG 12 SWOT Analysis: Gilead Sciences, Inc.
FIG 13 SWOT Analysis: ImmunityBio, Inc.
FIG 14 SWOT Analysis: F. Hoffmann-La Roche Ltd.
FIG 15 SWOT Analysis: Theratechnologies Inc.
FIG 16 SWOT Analysis: Viriom, Inc.
FIG 17 Swot Analysis: AbbVie, Inc.
FIG 18 SWOT Analysis: Brii Biosciences Limited
FIG 19 SWOT Analysis: Shionogi & Co., Ltd.
FIG 20 SWOT Analysis: Boehringer Ingelheim International GmbH

Purchase Full Report of
HIV Injection Market

Buy Now

Avail up to 60% discount on subscription plans on

SUBSCRIPTION MODEL